Eight-year survival study of treated hypertension at the dunedin hypertension clinic 1953-1977

Journal of Hypertension, Supplement

Volumn 6, Issue 4, 1988, Pages S634-S636

  Waal Manning, Hendrika J ^a   Paulin, Judith M ^a   Wallis, Truen A ^a   Olaf Simpson, F ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Eight year survival; Relative survival; Treated hypertension

Indexed keywords

FOLLOW UP; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; SURVIVAL;

FEMALE; FOLLOW-UP STUDIES; HUMAN; HYPERTENSION; MALE; NEW ZEALAND; SUPPORT, NON-U.S. GOV'T;

EID: 0024232274     PISSN: 09521178     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Smirk FH: Practical details of the methonium treatment of high pressure. NZ Med J 1950, 49:637-643.
2. Smirk FH, Alstad KS: Treatment of arterial hypertension by penta and hexamethonium salts. Br Med J, 1951, 1:1217- 1228.
3. Isles CG, Walker LM, Beevers GD, Brown I, Cameron HL, Clarke J, Hawthorne V, Hole D, Lever AF, Robertson JWK, Wapshaw JA: Mortality in patients of the Glasgow Blood Pressure Clinic. J Hypertension 1986, 4:141-156.
4. Trafford JAP, Horn CR, O’Neal H, McGonigle R, Halford-Maw L, Evans R: Five year follow-up of effects of treatment of mild and moderate hypertension. Br Med J 1981, 282:1111.
5. Breckenridge A, Dollery CT, Parry EHO: Prognosis of treated hypertension. Q J Med 1970, 39:411-429.
6. Bauer GE: The changing pattern of hypertensive disease. Med J Aust 1986, 1:698-723.
7. Bulpitt CJ, Clifton P, Dollery CT, Harper GS, Beilin LJ, Coles EC, Gear JSS, Johnson BF: Risk factors for death in treated hypertensive patients. Lancet 1979, ii:134-137.
8. Cruickshank JM, Penned K, Sorman AE, Thorp JM, Zacharias FM, Zacharias FJ: Low mortality from all causes, including myocardial infarction, in well-controlled hypertensives treated with a beta-blocker plus other antihypertensives. J Hypertension 1987, 5:489-498.
9. Bulpitt CJ: Prognosis of treated hypertension 1951-1981. Br J Clin Pharmacol 1982, 13:73-79.
10. The IPPPSH Collaborative Group: Cardiovascular risk and risk factors in a randomized trial of treatment based on the beta-blocker oxprenolol: the International Prospective Primary Prevention Study in Hypertension (IPPPSH). J Hypertension 1985, 3:379-382.